
【レポートの概要(一部)】
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
• Market outlook
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Immunosuppressants – Market size and forecast 2019-2024
• Supplementary medications – Market size and forecast 2019-2024
• Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2019-2024
• Europe – Market size and forecast 2019-2024
• Asia – Market size and forecast 2019-2024
• ROW – Market size and forecast 2019-2024
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Advent of techniques for organ transplantation
• Increasing strategic alliances
• Growing international collaborations for organ transplantation
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• AbbVie Inc.
• Astellas Pharma Inc.
• Cadila Healthcare Ltd.
• F. Hoffmann-La Roche Ltd.
• Mylan NV
• Novartis AG
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Veloxis Pharmaceuticals A/S
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
Exhibit 01: Global pharmaceuticals market
Exhibit 02: Segments of global pharmaceuticals market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendor key offerings
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: Product – Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: Immunosuppressants – Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Immunosuppressants – Year-over-year growth 2020-2024 (%)
Exhibit 22: Supplementary medications – Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Supplementary medications – Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America – Year-over-year growth 2020-2024 (%)
Exhibit 30: Top 3 countries in North America
Exhibit 31: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 32: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 33: Top 3 countries in Europe
Exhibit 34: Objectives of European Patients’ Forum
Exhibit 35: Asia – Market size and forecast 2019-2024 ($ millions)
Exhibit 36: Asia – Year-over-year growth 2020-2024 (%)
Exhibit 37: Proportion of geriatric population in Asia 2009 and 2018 (% of total population)
Exhibit 38: Top 3 countries in Asia
Exhibit 39: ROW – Market size and forecast 2019-2024 ($ millions)
Exhibit 40: ROW – Year-over-year growth 2020-2024 (%)
Exhibit 41: Top 3 countries in ROW
Exhibit 42: Key leading countries
Exhibit 43: Market opportunity
Exhibit 44: Benefits of multiple dosage forms of drugs
Exhibit 45: Side effects of immunosuppressants
Exhibit 46: Demand-supply imbalance of organ transplantation 2011-2015
Exhibit 47: Impact of drivers and challenges
Exhibit 48: Vendor landscape
Exhibit 49: Landscape disruption
Exhibit 50: Vendors covered
Exhibit 51: Vendor classification
Exhibit 52: Market positioning of vendors
Exhibit 53: AbbVie Inc. – Vendor overview
Exhibit 54: AbbVie Inc. – Business segments
Exhibit 55: AbbVie Inc. – Organizational developments
Exhibit 56: AbbVie Inc. – Geographic focus
Exhibit 57: AbbVie Inc. – Key offerings
Exhibit 58: AbbVie Inc. – Key customers
Exhibit 59: Astellas Pharma Inc. – Vendor overview
Exhibit 60: Astellas Pharma Inc. – Business segments
Exhibit 61: Astellas Pharma Inc. – Organizational developments
Exhibit 62: Astellas Pharma Inc. – Geographic focus
Exhibit 63: Astellas Pharma Inc. – Key offerings
Exhibit 64: Astellas Pharma Inc. – Key customers
Exhibit 65: Cadila Healthcare Ltd. – Vendor overview
Exhibit 66: Cadila Healthcare Ltd. – Business segments
Exhibit 67: Cadila Healthcare Ltd. – Organizational developments
Exhibit 68: Cadila Healthcare Ltd. – Geographic focus
Exhibit 69: Cadila Healthcare Ltd. – Key offerings
Exhibit 70: Cadila Healthcare Ltd. – Key customers
Exhibit 71: F. Hoffmann-La Roche Ltd. – Vendor overview
Exhibit 72: F. Hoffmann-La Roche Ltd. – Business segments
Exhibit 73: F. Hoffmann-La Roche Ltd. – Organizational developments
Exhibit 74: F. Hoffmann-La Roche Ltd. – Geographic focus
Exhibit 75: F. Hoffmann-La Roche Ltd. – Segment focus
Exhibit 76: F. Hoffmann-La Roche Ltd. – Key offerings
Exhibit 77: F. Hoffmann-La Roche Ltd. – Key customers
Exhibit 78: Mylan NV – Vendor overview
Exhibit 79: Mylan NV – Business segments
Exhibit 80: Mylan NV – Organizational developments
Exhibit 81: Mylan NV – Geographic focus
Exhibit 82: Mylan NV – Segment focus
Exhibit 83: Mylan NV – Key offerings
Exhibit 84: Mylan NV – Key customers
Exhibit 85: Novartis AG – Vendor overview
Exhibit 86: Novartis AG – Business segments
Exhibit 87: Novartis AG – Organizational developments
Exhibit 88: Novartis AG – Geographic focus
Exhibit 89: Novartis AG – Segment focus
Exhibit 90: Novartis AG – Key offerings
Exhibit 91: Novartis AG – Key customers
Exhibit 92: Pfizer Inc. – Vendor overview
Exhibit 93: Pfizer Inc. – Business segments
Exhibit 94: Pfizer Inc. – Organizational developments
Exhibit 95: Pfizer Inc. – Geographic focus
Exhibit 96: Pfizer Inc. – Segment focus
Exhibit 97: Pfizer Inc. – Key offerings
Exhibit 98: Pfizer Inc. – Key customers
Exhibit 99: Sun Pharmaceutical Industries Ltd. – Vendor overview
Exhibit 100: Sun Pharmaceutical Industries Ltd. – Business segments
Exhibit 101: Sun Pharmaceutical Industries Ltd. – Organizational developments
Exhibit 102: Sun Pharmaceutical Industries Ltd. – Geographic focus
Exhibit 103: Sun Pharmaceutical Industries Ltd. – Key offerings
Exhibit 104: Sun Pharmaceutical Industries Ltd. – Key customers
Exhibit 105: Teva Pharmaceutical Industries Ltd. – Vendor overview
Exhibit 106: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibit 107: Teva Pharmaceutical Industries Ltd. – Organizational developments
Exhibit 108: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibit 109: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibit 110: Teva Pharmaceutical Industries Ltd. – Key customers
Exhibit 111: Veloxis Pharmaceuticals A/S – Vendor overview
Exhibit 112: Veloxis Pharmaceuticals A/S – Business segments
Exhibit 113: Veloxis Pharmaceuticals A/S – Organizational developments
Exhibit 114: Veloxis Pharmaceuticals A/S – Geographic focus
Exhibit 115: Veloxis Pharmaceuticals A/S – Key offerings
Exhibit 116: Veloxis Pharmaceuticals A/S – Key customers
Exhibit 117: Validation techniques employed for market sizing
Exhibit 118: Definition of market positioning of vendors
【レポート販売概要】
■ タイトル:心臓移植治療薬の世界市場:製品別、地域別■ 英文:Heart Transplantation Therapeutics Market by Product and Geography - Forecast and Analysis 2020-2024
■ 発行日:2019年12月6日
■ 調査会社:Technavio
■ 商品コード:IRTNTR40272
■ 調査対象地域:グローバル
- 木材用コーティング剤の世界市場:樹脂種類別(ポリウレタン、ニトロセルロース、アクリル、不飽和ポリエステルなど)、技術別(水性、従来型固形溶剤、高固形溶剤、粉体塗装、放射線硬化など)、エンドユーズ別(家具、建具、フローリング、その他)The global wood coatings market was valued at $7,800.0 million in 2018, and is projected to reach $11,985.8 million by 2025, growing at a CAGR of 6.3% from 2020 to 2025. Wood coating refers to the process of refining or protecting a wooden surface, especially in the production of furniture where it represents between 5 and 30% of manufacturing costs. Moreover, the use of wood coating enhances the …
- 放射線量管理製品の世界市場:放射線量トラッキング、モニタリング、解析ソフトウェア、コンサルティングサービスPresently, radiation dose management is a rising concern in the healthcare industry. The radiation dose management market is experiencing tremendous growth owing to the increasing demand for patient safety and adherence to stringent regulations regarding patient dose exposure. The advent of radiation dose management solutions has modernized the management of radiation dose in radiology departments …
- 世界のヘリコプター・シミュレータ市場:Global Helicopter Simulators Market 2014-2018TechNavio's analysts forecast the Global Helicopter Simulators market to grow at a CAGR of 2.80 percent over the period 2013-2018. One of the key factors contributing to this market growth is the growing demand for commercial aircrafts. The Global Helicopter Simulators market has also been witnessing the increasing demand for full flight simulators. However, the high initial cost of simulators cou …
- 世界の多要素認証市場動向(2012-2016)TechNavio's analysts forecast the Global Multi-factor Authentication market to grow at a CAGR of 19.1 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing number of government regulatory requirements. The Global Multi-factor Authentication market has also been witnessing an increasing popularity of phone-based authentication solutions. Howe …
- クラウド型マイクログリッドサービス(MaaS)の世界市場予測2022The microgrid as a service (MaaS) market was valued at USD 774.9 Million in 2015 and is expected to reach USD 2,241.6 Million by 2022, at a CAGR of 15.86% during the forecast period. Reduction in operational costs and negligible upfront investments by MaaS end users, rising demand from MaaS from hospitals, universities, and remote regions, and high investments by governments in microgrid infrastru …
- アジア太平洋の物流サービス市場2016-2020About Logistics Market in the APAC Region Logistics is an important element of supply chain management (SCM). It includes the transportation, storage, and distribution of goods from the point of origin to the destination. Customers outsource their logistics and transportation functions to service providers that specialize in handling logistics functions like freight and forwarding, transportation, …
- 世界のジオマーケティングソフトウェア市場:展開別、ロケーション別、地域別Global Geomarketing Software Market: About this market Technavio’s geomarketing software market analysis considers sales from both outdoor and indoor locations. Our study also finds the sales of geomarketing software in APAC, Europe MEA, North America, and South America. In 2019, the outdoor segment had a significant market share, and this trend is expected to continue over the forecast period. Fa …
- 先端巨大症/巨人症治療薬の世界市場機会分析OpportunityAnalyzer: Acromegaly and Gigantism - Opportunity Analysis and Forecast to 2018 Summary GlobalData estimates the 2013 sales for acromegaly and gigantism at approximately $588m across the 6MM covered in this report. The market will grow moderately at a CAGR of 3.74% during the five year forecast period, generating sales of approximately $707m at the end of 2018. Growing at a CAGR of 4.58% …
- 冷凍・冷蔵倉庫の世界市場2016-2020About the Refrigerated Warehousing Market Refrigerated warehouses are an important segment of the supply chain that involves the storage of temperature-sensitive goods. Refrigerated storage helps in the storage of perishable goods during the flow of the cold chain supply. The increase in international trade has increased the need for the storage of food products from the producers to end-users in …
- 透明ディスプレイ市場動向及び市場機会(2014-2021)NanoMarkets believes that the market for transparent displays is about to expand dramatically. “Smart glasses,” such as Google Glass and Augmented Reality (AR) applications have focused attention on displays that can simultaneously display information and function as windows on the real world. Display firms have begun to respond to these major trends with novel types of transparent displays. To do …
- モバイルコマース技術(Mobile Commerce Technologies)Mobile commerce is expected to reach $10 B USD by the end of 2013, representing an annual compound growth rate of 39% that will continue over the next five years. M-commerce growth is driven by many factors including the introduction of the various new use cases involving tablet PC's and the next generation smartphones. In addition, new business models involving social networking, user-generated c …
- タイの小売市場2016-2020About the Thailand Retail Market The market is expected to post a positive growth during the forecast period. In 2015, the grocery sector accounted for the majority of the market with a share of 82.01%. Increasing urbanization, changing lifestyles, and demand for sophisticated products will be some of the major drivers propelling the market's growth over the next five years. An increase in consume …
- 世界のジャッキアップリグ市場2015The Global Jackup Rig Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Jackup Rig industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Jackup Rig market analysis is provided for the international markets including development trends, competitive lands …
- ジンジャービールの世界市場:種類別(ゴールデン、ドライ)、販売チャネル別(コンビニエンスストア、スーパーマーケット・ハイパーマーケット、専門店)、地域別予測Global Ginger Beer Market Size Study Type (Golden & Dry), by Distribution Channel (Convenience Store, Supermarket/ Hypermarket, &Specialist store) and by Region - Global Forecast 2017- 2025 Global Ginger Beer Market to reach USD xxxx billion by 2025. Global Ginger Beer Market valued approximately USD xxxx billion in 2016 is anticipated to grow with a healthy growth rate of more than xx% over the f …
- US Flow Cytometry Market 2014: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive LandscapeComplete report $6,700. DataPack (test volumes, sales forecasts, supplier shares) $4,300.This report presents a comprehensive analysis of the US flow cytometry market, including:Major issues pertaining to the US flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.Five-year volume …